Villanova Investment Management Co LLC Has $1.33 Million Stock Position in Phibro Animal Health Corporation $PAHC

Villanova Investment Management Co LLC reduced its holdings in Phibro Animal Health Corporation (NASDAQ:PAHC) by 63.9% in the third quarter, HoldingsChannel reports. The firm owned 32,829 shares of the company’s stock after selling 58,029 shares during the period. Villanova Investment Management Co LLC’s holdings in Phibro Animal Health were worth $1,328,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in the business. EverSource Wealth Advisors LLC boosted its holdings in shares of Phibro Animal Health by 7,671.4% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,720 shares of the company’s stock worth $69,000 after buying an additional 2,685 shares in the last quarter. Tower Research Capital LLC TRC lifted its position in shares of Phibro Animal Health by 768.2% during the 2nd quarter. Tower Research Capital LLC TRC now owns 4,610 shares of the company’s stock valued at $118,000 after acquiring an additional 4,079 shares during the period. State of Wyoming boosted its stake in Phibro Animal Health by 148.8% during the second quarter. State of Wyoming now owns 6,608 shares of the company’s stock worth $169,000 after acquiring an additional 3,952 shares in the last quarter. Cornerstone Investment Partners LLC bought a new position in Phibro Animal Health during the third quarter worth $209,000. Finally, Balboa Wealth Partners acquired a new stake in Phibro Animal Health in the third quarter worth $216,000. 99.34% of the stock is owned by institutional investors and hedge funds.

Phibro Animal Health Price Performance

Shares of NASDAQ PAHC opened at $52.80 on Monday. The stock has a market cap of $2.14 billion, a price-to-earnings ratio of 23.47, a PEG ratio of 0.81 and a beta of 0.80. The company has a debt-to-equity ratio of 2.14, a quick ratio of 1.22 and a current ratio of 3.05. Phibro Animal Health Corporation has a fifty-two week low of $16.16 and a fifty-two week high of $56.30. The firm’s 50-day simple moving average is $42.44 and its 200 day simple moving average is $40.14.

Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings data on Wednesday, February 4th. The company reported $0.87 EPS for the quarter, topping the consensus estimate of $0.69 by $0.18. The firm had revenue of $373.91 million during the quarter, compared to the consensus estimate of $355.64 million. Phibro Animal Health had a return on equity of 38.28% and a net margin of 6.29%.Phibro Animal Health has set its FY 2026 guidance at 2.930-3.100 EPS. As a group, research analysts anticipate that Phibro Animal Health Corporation will post 1.95 earnings per share for the current fiscal year.

Phibro Animal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 25th. Shareholders of record on Wednesday, March 4th will be paid a dividend of $0.12 per share. The ex-dividend date is Wednesday, March 4th. This represents a $0.48 annualized dividend and a yield of 0.9%. Phibro Animal Health’s dividend payout ratio (DPR) is 21.33%.

Analyst Ratings Changes

Several brokerages have recently weighed in on PAHC. JPMorgan Chase & Co. upped their price objective on shares of Phibro Animal Health from $45.00 to $50.00 and gave the company an “overweight” rating in a report on Friday, November 7th. Morgan Stanley set a $49.00 price target on Phibro Animal Health in a research note on Friday, February 6th. Weiss Ratings reissued a “buy (b-)” rating on shares of Phibro Animal Health in a research note on Monday, December 29th. Finally, Zacks Research downgraded Phibro Animal Health from a “strong-buy” rating to a “hold” rating in a report on Monday, February 9th. Two analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $37.50.

Insider Transactions at Phibro Animal Health

In other news, CEO Jack Bendheim sold 110,842 shares of the company’s stock in a transaction on Thursday, February 5th. The shares were sold at an average price of $48.38, for a total value of $5,362,535.96. Following the completion of the sale, the chief executive officer owned 122,958 shares in the company, valued at $5,948,708.04. This represents a 47.41% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Over the last quarter, insiders have sold 293,920 shares of company stock worth $13,833,025. 50.13% of the stock is owned by insiders.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation (NASDAQ: PAHC) is a diversified global animal health and mineral nutrition company headquartered in Teaneck, New Jersey. The company develops, manufactures and markets a broad range of pharmaceutical, mineral nutrition and performance products designed to support the health and productivity of livestock, companion animals and aquaculture species. Phibro’s portfolio includes vaccines, anti-infective therapies, coccidiostats, disinfectants, premix minerals and specialty feed additives aimed at enhancing growth, immunity and overall animal well-being.

The company operates through three principal business segments: Animal Health, Mineral Nutrition and Performance Products.